Government-Owned Inventions; Availability for Licensing, 42719 [2016-15441]

Download as PDF Federal Register / Vol. 81, No. 126 / Thursday, June 30, 2016 / Notices Background Information on NICEATM: NICEATM conducts data analyses, workshops, independent validation studies, and other activities to assess new, revised, and alternative test methods and strategies. NICEATM also provides support for the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM). The ICCVAM Authorization Act of 2000 (42 U.S.C. 285l–3) provides authority for ICCVAM and NICEATM in the development of alternative test methods. Information about NICEATM and ICCVAM is found at https:// ntp.niehs.nih.gov/go/niceatm and https://ntp.niehs.nih.gov/go/iccvam. Dated: June 24, 2016. John R. Bucher, Associate Director, National Toxicology Program. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing National Institutes of Health, Notice. The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 209 and 37 CFR part 404 to achieve expeditious commercialization of results of federally-funded research and development. FOR FURTHER INFORMATION CONTACT: Licensing information may be obtained by emailing the indicated licensing contact at the National Heart, Lung, and Blood, Office of Technology Transfer and Development Office of Technology Transfer, 31 Center Drive Room 4A29, MSC2479, Bethesda, MD 20892–2479; telephone: 301–402–5579. A signed Confidential Disclosure Agreement may be required to receive any unpublished information. SUPPLEMENTARY INFORMATION: Technology description follows. SUMMARY: National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. mstockstill on DSK3G9T082PROD with NOTICES BILLING CODE 4140–01–P ACTION: DEPARTMENT OF HEALTH AND HUMAN SERVICES Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel. Date: July 27, 2016. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892, (Telephone Conference Call). Contact Person: James T. Snyder, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities/ Room 3G31B, National Institutes of Health, NIAID, 5601 Fishers Lane MSC 9823, Bethesda, MD 20892–9823, (240) 669–5060, james.snyder@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, Jkt 238001 [FR Doc. 2016–15443 Filed 6–29–16; 8:45 am] HHS. BILLING CODE 4140–01–P 20:01 Jun 29, 2016 Dated: June 24, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. AGENCY: [FR Doc. 2016–15444 Filed 6–29–16; 8:45 am] VerDate Sep<11>2014 and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Multi-Photon Microscopy System Configured for Multiview Non-Linear Optical Imaging This invention is a microscopy device and system for multi-photon microscopy utilizing multi-view nonlinear optical imaging. Nonlinear optical imaging remains the premier technique for deep-tissue imaging in which typically a multi photon arrangement may be used to illuminate and excite a sample. However, the penetration depth, signal-to-noise ratio, and resolution of this technique is ultimately limited by scattering. The present system addresses these issues by sequential excitation of a sample through three or more objective lenses oriented at different axes intersecting the sample. Each objective lens is capable of focused sequential excitation that elicits fluorescence emissions from the excited sample, which is then PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 42719 simultaneously detected by each respective objective lens along a respective longitudinal axis. Including multiple lenses will improve the penetration depth and at the same time decrease the loss of detail because of scattering. The system also can overcome losses in spatial resolution because of the scattering of the excitation and emission light. Potential Commercial Applications: —High resolution multi-photon microscopy —Deep tissue visualization —Competitive Advantages: —Improved signal-to-noise ratio —improved spatial resolution —Development Stage: • Prototype Inventors: Yicong Wu (NIBIB), Hari Shroff (NIBIB), Jianyong Tang (NIAID), Ronald Germain (NIAID). Intellectual Property: HHS Reference No. E–229–2015/0; U.S. Provisional Patent Application 62/210,153 filed August 26, 2015. Licensing Contact: Michael Shmilovich, Esq, CLP; 301–435–5019; shmilovm@mail.nih.gov. Dated: June 24, 2016. Michael Shmilovich, Senior Licensing and Patenting Manager, National Heart, Lung, and Blood Institute, Office of Technology Transfer and Development. [FR Doc. 2016–15441 Filed 6–29–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Member Conflict SEP. Date: July 6, 2016. E:\FR\FM\30JNN1.SGM 30JNN1

Agencies

[Federal Register Volume 81, Number 126 (Thursday, June 30, 2016)]
[Notices]
[Page 42719]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-15441]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Government-Owned Inventions; Availability for Licensing

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The inventions listed below are owned by an agency of the U.S. 
Government and are available for licensing in the U.S. in accordance 
with 35 U.S.C. 209 and 37 CFR part 404 to achieve expeditious 
commercialization of results of federally-funded research and 
development.

FOR FURTHER INFORMATION CONTACT: Licensing information may be obtained 
by emailing the indicated licensing contact at the National Heart, 
Lung, and Blood, Office of Technology Transfer and Development Office 
of Technology Transfer, 31 Center Drive Room 4A29, MSC2479, Bethesda, 
MD 20892-2479; telephone: 301-402-5579. A signed Confidential 
Disclosure Agreement may be required to receive any unpublished 
information.

SUPPLEMENTARY INFORMATION: Technology description follows.

Multi-Photon Microscopy System Configured for Multiview Non-Linear 
Optical Imaging

    This invention is a microscopy device and system for multi-photon 
microscopy utilizing multi-view nonlinear optical imaging. Nonlinear 
optical imaging remains the premier technique for deep-tissue imaging 
in which typically a multi photon arrangement may be used to illuminate 
and excite a sample. However, the penetration depth, signal-to-noise 
ratio, and resolution of this technique is ultimately limited by 
scattering. The present system addresses these issues by sequential 
excitation of a sample through three or more objective lenses oriented 
at different axes intersecting the sample. Each objective lens is 
capable of focused sequential excitation that elicits fluorescence 
emissions from the excited sample, which is then simultaneously 
detected by each respective objective lens along a respective 
longitudinal axis. Including multiple lenses will improve the 
penetration depth and at the same time decrease the loss of detail 
because of scattering. The system also can overcome losses in spatial 
resolution because of the scattering of the excitation and emission 
light.

Potential Commercial Applications:
    --High resolution multi-photon microscopy
    --Deep tissue visualization
--Competitive Advantages:
    --Improved signal-to-noise ratio
    --improved spatial resolution
--Development Stage:
     Prototype

    Inventors: Yicong Wu (NIBIB), Hari Shroff (NIBIB), Jianyong Tang 
(NIAID), Ronald Germain (NIAID).
    Intellectual Property: HHS Reference No. E-229-2015/0; U.S. 
Provisional Patent Application 62/210,153 filed August 26, 2015.
    Licensing Contact: Michael Shmilovich, Esq, CLP; 301-435-5019; 
shmilovm@mail.nih.gov.

    Dated: June 24, 2016.
Michael Shmilovich,
Senior Licensing and Patenting Manager, National Heart, Lung, and Blood 
Institute, Office of Technology Transfer and Development.
[FR Doc. 2016-15441 Filed 6-29-16; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.